April 2024 in “European Journal of Dermatology” This study suggests that the PPP2R3C gene may confer susceptibility to psoriatic arthritis and psoriasis vulgaris in Chinese patients, with additional possible associations involving IL-23R, ERN1, IFIH1, and KIF3A genes.
February 2024 in “Frontiers in Cell and Developmental Biology” This study found that eribulin-based chemotherapy resulted in longer median progression-free and overall survival, with fewer side effects, for advanced triple-negative breast cancer patients compared to other chemotherapy options.
January 2024 in “Wiadomości Lekarskie” This lecture summarizes current knowledge on robotic surgery, examining its advantages and limitations compared to traditional methods, and highlights the need for further research and training in the field.
August 2023 in “Journal of Cosmetic Dermatology” This study found that combining fractional ablative erbium YAG laser with minoxidil led to slightly better dermoscopy scores than minoxidil alone in male patients with moderate to severe androgenetic alopecia, although no significant difference was observed in photography scores between the two groups.
This article describes the significant emotional and psychological impact of female pattern hair loss on menopausal women, leading many to seek medical treatment to improve their quality of life and self-esteem.
In this study, collagen type I, skin fibroblasts, and macrophages did not show remarkable changes in androgenic alopecia patients' scalp tissues after treatment with 1550 nm fractional Er:Glass laser, despite improved hair regrowth.
This study found that DHT induces apoptosis in human keratinocyte cells via ERK activation, independently of androgen receptors and the Wnt/β-catenin pathway.
August 2026 in “Frontiers in Nutrition” This study reports that combining ergothioneine, collagen peptides, and sodium hyaluronate improved skin parameters like hydration, elasticity, and wrinkle reduction in Chinese women, while ex vivo data indicated enhanced antioxidant action and structural support, suggesting potential for anti-aging nutricosmetics.
July 2026 in “Regenerative medicine reports .” This study concluded that nanoparticle-based delivery systems may significantly enhance wound healing and tissue regeneration in third-degree burns, though challenges like nanoparticle variability and cytotoxicity remain.
June 2026 in “British Journal of Dermatology” In this case study, a woman with alopecia areata experienced significant hair regrowth after starting ritlecitinib but developed an acneiform eruption, leading to the discontinuation of the drug and subsequent hair loss relapse; the eruption suggests a treatment-limiting adverse effect of JAK inhibitors.
May 2026 in “Scientific Reports” In this study, researchers overexpressed Lrig3 in mouse skin and observed hair loss linked to changes in skin protein profiles and signaling pathways, suggesting a potential role for Lrig3 in maintaining skin homeostasis.
May 2026 in “International Journal of Drug Delivery Technology” This case study highlights Erythromelanosis follicularis faciei et colli as an easily overlooked pigmentary disorder characterized by a distinctive triad requiring precise diagnosis for effective patient counseling and cosmetic management.
April 2026 in “The Journal of Urology” In this large retrospective study, low-dose finasteride for androgenetic alopecia was associated with an increased risk of erectile dysfunction at one and three years among men aged 18-45.
April 2026 in “The Journal of Sexual Medicine” This study described the population-level incidence of erectile dysfunction in men using finasteride for androgenetic alopecia, finding a varied risk that highlights the complexity of interpreting sexual side effects.
March 2026 in “The Korean Society for Veterinary Nursing” In this study, Eremochloa ophiuroides-derived fractions were found to significantly promote hair regrowth in a mouse model, demonstrating effects comparable to minoxidil and suggesting potential as natural hair growth agents through modulation of follicular activation markers and growth-regulatory factors.
March 2026 in “SKIN The Journal of Cutaneous Medicine” This study demonstrated that litifilimab significantly reduced disease activity in cutaneous lupus erythematosus by Week 16, with improvements most notable in sunlight-exposed skin areas.
February 2026 in “MedBA Medicine” This study identified potential new adverse drug reaction signals for erlotinib, used in lung and pancreatic cancer treatment, by analyzing a large dataset of case reports, indicating further clinical studies are necessary to confirm these findings.
February 2026 in “Immunity Inflammation and Disease” This study evaluated 386 patients with inborn errors of immunity and found that over half exhibited cutaneous, ocular, or hair manifestations, with bacterial skin infections and eczema being particularly prevalent. These findings may aid early diagnosis, especially in pediatric cases.
January 2026 in “Annals of Medicine and Surgery” This article corrects an author name in a previously published study on the application of retinoids for androgenic alopecia, without presenting new research findings.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This document promotes a 25% discount using the code AVA25 on Erthwellness's natural health supplements, detailing how to apply the code and the benefits of their products, with no new research findings reported.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This document promotes an Erthwellness discount code that offers a 25% reduction on all their natural health products, without presenting any new research findings.
December 2025 in “Journal of Pakistan Association of Dermatologists” This case report highlights a rare instance of erosive pustular dermatosis of the scalp in a patient on afatinib, underlining the importance of early recognition and management of this adverse effect.
December 2025 in “Annals of African Medicine” December 2025 in “Asthma Allergy Immunology” This study found that among pediatric patients with inborn errors of immunity, severe COVID-19 was linked to chronic lung disease, hypogammaglobulinemia, and musculoskeletal abnormalities, with chronic pulmonary illness being a major risk factor, while long-term effects included fatigue, hair loss, and red eye.
December 2025 in “Portuguese Journal of Dermatology and Venereology” In this study, researchers conducted a retrospective analysis of 16 cases of erosive palmoplantar lichen planus in North East India, finding a higher prevalence in pediatric and male patients, with common clinical features including plantar involvement and histopathological indicators such as basal cell degeneration.
December 2025 in “Medical & Clinical Case Reports Journal” This article suggests that scalp erythrasma caused by Corynebacterium minutissimum may be underdiagnosed and that oral antibiotics used for other conditions could reduce its risk.
December 2025 in “Indian Journal of Dermatology” This case report describes a 24-year-old male with eruptive vellus hair cysts on his forehead and explores the use of extraction videodermoscopy as a new, less invasive diagnostic method, potentially replacing the need for skin biopsy in diagnosing such skin conditions.
November 2025 in “Clinics and Practice” This case report describes a rare and severe systemic reaction to red tattoo ink, including erythroderma, alopecia universalis, anhidrosis, and vitiligo, highlighting significant diagnostic and therapeutic challenges.
November 2025 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” This study documented a case of an 11-month-old with PKU who developed acrodermatitis enteropathica-like symptoms due to severe phenylalanine deficiency, requiring dietary adjustment to restore phenylalanine levels.
October 2025 in “EMJ Dermatology” Histopathology is crucial for accurately diagnosing eruptive vellus hair cysts.